Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Drakaki

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Current Issues in Molecular Biology|April 26, 2024
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic CancerDimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, et al.
Clinical Genitourinary Cancer|December 5, 2017
The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy EraSandy T Liu, Gavin Hui, Colleen Mathis, et al.
World Journal of Urology|May 4, 2020
VEGF inhibition in urothelial cancer: the past, present and futureSanaz Ghafouri, Aaron Burkenroad, Morgan Pantuck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 27, 2024
Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell TumorsYang Zong, Rongrong Huang, Mireille Bitar, et al.
Drug Design, Development and Therapy|February 9, 2018
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinomaIzak Faiena, Amy L Cummings, Anna M Crosetti, et al.
Cureus|July 10, 2025
Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the CulpritDavid Shabsovich, Nikhita Kathuria-Prakash, Jiajia Zhang, et al.
The Journal of Urology|July 28, 2016
Immunotherapy for the Treatment of Urothelial CarcinomaNicholas M Donin, Andrew T Lenis, Stuart Holden, et al.
AIDS (London, England)|July 11, 2017
Unique microRNA expression in the colonic mucosa during chronic HIV-1 infectionJennifer A Fulcher, Georgios Koukos, Marina Koutsioumpa, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial CarcinomaGavin Hui, Dimitrios Stefanoudakis, Yuliya Zektser, et al.
BMC Cancer|July 25, 2015
Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathwayAlexandra Drakaki, Maria Hatziapostolou, Christos Polytarchou, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Current Issues in Molecular Biology|April 26, 2024
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic CancerDimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, et al.
Clinical Genitourinary Cancer|December 5, 2017
The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy EraSandy T Liu, Gavin Hui, Colleen Mathis, et al.
World Journal of Urology|May 4, 2020
VEGF inhibition in urothelial cancer: the past, present and futureSanaz Ghafouri, Aaron Burkenroad, Morgan Pantuck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 27, 2024
Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell TumorsYang Zong, Rongrong Huang, Mireille Bitar, et al.
Drug Design, Development and Therapy|February 9, 2018
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinomaIzak Faiena, Amy L Cummings, Anna M Crosetti, et al.
Cureus|July 10, 2025
Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the CulpritDavid Shabsovich, Nikhita Kathuria-Prakash, Jiajia Zhang, et al.
The Journal of Urology|July 28, 2016
Immunotherapy for the Treatment of Urothelial CarcinomaNicholas M Donin, Andrew T Lenis, Stuart Holden, et al.
AIDS (London, England)|July 11, 2017
Unique microRNA expression in the colonic mucosa during chronic HIV-1 infectionJennifer A Fulcher, Georgios Koukos, Marina Koutsioumpa, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial CarcinomaGavin Hui, Dimitrios Stefanoudakis, Yuliya Zektser, et al.
BMC Cancer|July 25, 2015
Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathwayAlexandra Drakaki, Maria Hatziapostolou, Christos Polytarchou, et al.
Pageof 14